INmune Bio Inc (NASDAQ:INMB)

6.80
Delayed Data
As of May 27
 +0.47 / +7.42%
Today’s Change
4.63
Today|||52-Week Range
30.37
-33.33%
Year-to-Date

Today’s Trading

Previous close6.33
Today’s open6.47
Day’s range6.47 - 6.95
Volume6,287
Average volume (3 months)154,082
Market cap$132.1M
Data as of 3:59pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)-86.38%
Earnings growth (this year)-5.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,558.12%
P/E ratioNM
Price/Sales909.01
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.08-2.52%
URGNUrogen Pharma Ltd+0.27+5.22%
TCRTAlaunos Therapeutics...+0.05+10.73%
SELBSelecta Biosciences ...+0.07+9.96%
Data as of 4:00pm ET, 05/27/2022

Financials

Next reporting dateAugust 15, 2022
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$181.0K
Annual profit (last year)-$30.3M
Net profit margin-16,762.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boca Raton, Florida

Forecasts